See All Slides - tctmd.com

Slides

Presentation TCT 2012

When Should MVD be Managed Medically?

Presenter: William Boden

October 23, 2012

Presentation TCT 2012

Blue-Toe Syndrome: Does Thrombolysis Have a Place?

Presenter: Thomas McNamara

October 23, 2012

Presentation TCT 2012

Surgical Perspectives of the MitraClip and Its Role in the Treatment of Severe Degenerative and Functional MR

Presenter: Hendrik Treede

October 23, 2012

Presentation TCT 2012

Pathogenesis of Vulnerable Plaque 2012: What's New?

Presenter: Renu Virmani

October 23, 2012

Presentation TCT 2012

TCT-1. Risk Factors for Cerebral Embolization After Carotid Artery Stenting with Embolic Protection – A DW–MRI Study in 827 Patients

Presenter: Klaudija Bijuklic

October 23, 2012

Presentation TCT 2012

HFPEF: Overview of Pathophysiology and Therapies

Presenter: William Little

October 23, 2012

Presentation TCT 2012

Essentials of Carotid Artery Diseases: Guidelines, Assessment, and Outcomes

Presenter: Jose Wiley

October 23, 2012

Presentation TCT 2012

First-in-Man Results with a Myolimus-Eluting Bioabsorbable PLLA-based Vascular Scaffold (Elixir DESolve)

Presenter: Stefan Verheye

October 23, 2012

Presentation TCT 2012

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Con!

Presenter: Andrej Schmidt

October 23, 2012

Presentation TCT 2012

TCT-72. Impact of Gender on Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: Pooled Analysis from the SPIRIT II, III and IV Trials

Presenter: Usman Baber

October 23, 2012

Advertisement

Slides

When Should MVD be Managed Medically?

Blue-Toe Syndrome: Does Thrombolysis Have a Place?

Surgical Perspectives of the MitraClip and Its Role in the Treatment of Severe Degenerative and Functional MR

Pathogenesis of Vulnerable Plaque 2012: What's New?

TCT-1. Risk Factors for Cerebral Embolization After Carotid Artery Stenting with Embolic Protection – A DW–MRI Study in 827 Patients

HFPEF: Overview of Pathophysiology and Therapies

Essentials of Carotid Artery Diseases: Guidelines, Assessment, and Outcomes

First-in-Man Results with a Myolimus-Eluting Bioabsorbable PLLA-based Vascular Scaffold (Elixir DESolve)

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Con!

TCT-72. Impact of Gender on Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: Pooled Analysis from the SPIRIT II, III and IV Trials

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content